Microbiome Sequencing Services Market Size, Share & Trends Analysis Report By Technology, By Application, By Laboratory Type, By End-user, By Region, And Segment Forecasts, 2023 To 2030

Microbiome sequencing decodes the genetic material of all the microorganisms in a sample, such as viruses, bacteria, fungi, and protists. It also offers more accurate and efficient microbe classification compared to traditional methods of identification, such as culturing or cloning.This method is a common process of studying bacterial taxonomy and phylogeny. The 16S rRNA gene is the most established genetic marker for bacterial identification and classification, as it consists of both hypervariable and highly conserved areas. The conserved areas can serve as universal primer binding sites for the amplification of the whole gene, whereas the hypervariable areas comprise species-specific sequences that can differentiate between different archaea and bacteria.

The microbiome refers to the genetic substance of the catalog of microbial taxa associated with humans. The microbiota influences a dynamic equilibrium in the human body, which can be altered by external stimuli and environmental factors. Metagenomics is a comparatively new area of research on microbial genomes within various environmental samples, which is gaining significance in microbiology. Introducing the ecological insight of microbiology is crucial to achieving real knowledge about the effect of microbiota on human health and disease. Moreover, the government invests huge funds in microbiome services plans to invent unique diagnostic and treatment procedures. Human microbiome projects help examine all the microorganisms in the human body.

Next-generation sequencing is a new high-rated sequencing technology that provides ultra-high speed and scalability. The technology is used to define the sequence of nucleotides in entire targeted areas of DNA or RNA. Next-generation sequencing has transformed the biological industry, allowing labs to perform a wide range of studies and applications of biological systems at a high level.

The market is driven by factors such as rising awareness among healthcare professionals on the availability of advanced microbiome sequencing services. Other factors, such as increasing demand for microbiome sequencing services for early disease detection, and high investment in next-generation sequencing, are likely to propel the market growth over the forecast period.

The market is segmented based on technology, application, laboratory type, end-user, and region. The technology segment is divided intosequencing by synthesis & ligation, short gun, targeted gene, sanger, RNA, and next-generation sequencing. The application segment is divided intoCNS diseases, gastrointestinal diseases, infectious diseases, oncology, and others. The laboratory type is segmented into wet labs and dry labs. The end-user segment is further segmented into pharmaceutical and biotechnology companies, academia/research institutes, and other end-users.

The market is anticipated to grow significantly in the forecast years, owing to the increasing demand for these services in North America, Europe, and Asia Pacific. The U.S. and Canada, the UK, France, Italy, Germany, Spain, Sweden, Denmark, Norway, China, Japan, India, Thailand, Australia, South Korea, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, UAE, and Kuwait are the major countries contributing to the market. Microbiomics A/S is a market player in the microbiome sequencing services industry, which have a high presence in the Europe region. In October 2022, the company announced the acquisition of MS-Omics. The acquisition will likely add leading expertise in metabolite profiling from MS-Omics to advance its systems biology platform further.

                        Microbiome Sequencing Services Market Segmentation

The market has witnessed growth in recent years due to technological advancements in the field of next-generation sequencing. Some of the companies operating in the market are Microbiome Insights Inc., Baseclear BV, Clinical Microbiomics AS, Merieux Nutrisciences Corporations, MR DNA, Metabiomics Corp., Rancho Biosciences, Second Genome, Zymo Research Corp., and Ubiome, Inc. The market players are engaged in developing and advanced services for capturing a huge share of the market.